Present Situation of MDR-TB in Asian Countries and the Possibility of MDR-TB Treatment by New Quinolones —— Satellite Symposium of the 14th Asia Pacific Congress on Diseases of the Chest, Bali, June 1995: Proceedings. Supplement Issue: Chemotherapy 1996, Vol. 42, Suppl. 3

----- 亚洲国家耐多药结核病现状及新喹诺酮类药物治疗耐多药结核病的可能性

ISBN: 9783805564069 出版年：1996 页码：39 S.Karger

This publication presents the latest data on the incidence of multi-drug resistant tuberculosis (MDR-TB) infections in Taiwan, China, Thailand, Indonesia and the US. The health care systems of these countries, both at the local and national level, are characterized, and the strategies of how they are dealing with this increasing problem are described. The need to supervise patients when they receive treatment is stressed. Results from clinical trials using ofloxacin as part of the anti-TB medication for treating MDR-TB are reported from each country. An overview of the global situation as well as a historical review and reasons for the development of MDR-TB together with clear-cut guidelines for prevention are also provided. The information compiled in this issue will be of great practical value to anyone involved in TB control and treatment, such as respiratory and infectious disease specialists, public health experts and government health organizations.